Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent: 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

Autor: Eisenstein, Eric L., Leon, Martin B. , Kandzari, David E. , Mauri, Laura §, Edwards, Rex, Kong, David F., Cowper, Patricia A., Anstrom, Kevin J.
Zdroj: In JACC: Cardiovascular Interventions December 2009 2(12):1199-1207
Databáze: ScienceDirect